Print

Suzette Kox nominated as Secretary General of the International Generic and Biosimilar medicines Association

IGBA, the International Generic and Biosimilar medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, announces today the nomination of Suzette Kox as Secretary General of the association. Her main role is to coordinate the IGBA activities as IGBA continues to expand its outreach relevant to its mission, priorities and operations.

Print

IGBA Reflection Paper on waiving bridging studies for biosimilar medicines applications

IGBA proposes a new international biosimilars framework allowing bridging studies to be waived in specific circumstances based on core scientific and regulatory principles established for current products.

Print

IGBA Position on Identification of Biological, including Biosimilar Medicines 2018 Update of Facts & Figures

IGBA Position on Identification of Biological, including Biosimilar Medicines 2018 Update of Facts & Figures.

Contact Info

2019-03-18IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

Rue des Pierres-du-Niton 17
1207 Geneva

Telephone: +32 (0)2 5346607
E-mails: 
This email address is being protected from spambots. You need JavaScript enabled to view it.  
or 
This email address is being protected from spambots. You need JavaScript enabled to view it.

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site